Inactive Instrument

FoxWayne Enterprises Acquisition Corp.

FOXW

US35166L1098

Aerami Therapeutics Holdings, Inc. and FoxWayne Enterprises Acquisition Corp. Mutually Agree to Terminate Business Combination Agreement

March 04, 2022 at 04:31 pm

DURHAM, N.C. and NEW YORK, March 4, 2022 /PRNewswire/ -- Aerami Therapeutics Holdings, Inc. ("Aerami"), a biopharmaceutical company focused on developing inhaled therapies to treat severe respiratory and chronic diseases, and FoxWayne Enterprises Acquisition Corp. (NASDAQ: FOXW) ("FoxWayne"), a publicly traded special purpose acquisition company ("SPAC"), announced today that they have mutually agreed to terminate their previously announced business combination agreement, effective immediately.

(PRNewsfoto/FoxWayne Enterprises Acquisition Corp)

In light of current unfavorable market conditions, Aerami and FoxWayne believe that terminating the business combination agreement is the best path forward for the parties and their respective stockholders.

FoxWayne has until April 22, 2022 to complete an initial business combination (unless such date is extended in accordance with FoxWayne's governing documents).

About Aerami

Aerami is a clinical stage biopharmaceutical company developing inhaled therapies to treat severe respiratory and chronic diseases. Aerami's lead development program is AER-901, a drug-device combination product candidate in Phase 1 for the treatment of pulmonary arterial hypertension. AER-901 is designed to improve drug uptake and deliver consistent, therapeutically effective, and well tolerated levels of a nebulized formulation of imatinib through once-a-day inhalation via the FOX^® device, which is both 510(k) cleared and CE marked and which the Company has licensed from Vectura Limited.

About FoxWayne

FoxWayne is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. FoxWayne is led by Chairman and Chief Executive Officer, Robb Knie.

Aerami Investor Contact:
CORE IR
Tel: 516-222-2560
investors@aerami.com

Aerami Media Contact:
Jules Abraham
CORE IR
Tel: 917-885-7378
julesa@coreir.com

FoxWayne Investor Contact:
Investor Relations
Tel: 917-284-8938
investors@foxwayne.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/aerami-therapeutics-holdings-inc-and-foxwayne-enterprises-acquisition-corp-mutually-agree-to-terminate-business-combination-agreement-301496112.html

SOURCE FoxWayne Enterprises Acquisition Corp

Latest news about FoxWayne Enterprises Acquisition Corp.

FoxWayne Enterprises Acquisition Corp.(NasdaqCM:FOXW) dropped from NASDAQ Composite Index	23-01-27	CI
Clover Inc. cancelled the acquisition of FoxWayne Enterprises Acquisition Corp. from a group of shareholders in a reverse merger transaction.	23-01-11	CI
FoxWayne Enterprises Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Clover Inc. entered into a definitive business combination agreement to acquire FoxWayne Enterprises Acquisition Corp. from a group of shareholders for approximately $160 million in a reverse merger transaction.	22-09-19	CI
FoxWayne Enterprises Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-10	CI
FoxWayne Enterprises Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-13	CI
FoxWayne Enterprises Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-31	CI
FoxWayne Enterprises Acquisition Corp. Auditor Raises 'Going Concern' Doubt	22-03-30	CI
Aerami Therapeutics Holdings, Inc. cancelled the acquisition of FoxWayne Enterprises Acquisition Corp. from FoxWayne Enterprises Acquisition Sponsor LLC and others in a reverse merger transaction.	22-03-03	CI
Aerami Therapeutics to Go Public Via Merger with Blank-Check Firm FoxWayne Enterprises	21-12-07	MT
FoxWayne Enterprises Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-05	CI
Foxwayne Enterprises Acquisition Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-11	CI
Aerami Therapeutics Holdings, Inc. executed a non-binding letter of intent to acquire FoxWayne Enterprises Acquisition Corp. from FoxWayne Enterprises Acquisition Sponsor LLC and others for approximately $250 million in a reverse merger transaction.	21-08-10	CI
Certain Class B Common Stock of FoxWayne Enterprises Acquisition Corp. are subject to a Lock-Up Agreement Ending on 19-JUL-2021.	21-07-18	CI
Foxwayne Enterprises Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-21	CI
Foxwayne Enterprises Acquisition Corp. Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	21-03-29	CI
FoxWayne Enterprises Acquisition Corp. Auditor Raises 'Going Concern' Doubt	21-03-28	CI
FoxWayne Enterprises Acquisition Corp.(NasdaqCM:FOXW) added to NASDAQ Composite Index	21-02-26	CI
FoxWayne Enterprises Acquisition Corp. announced that it has received $2.8 million in funding from FoxWayne Enterprises Acquisition Sponsor LLC	21-01-21	CI
FoxWayne Enterprises Acquisition Corp. has completed an IPO in the amount of $50 million.	21-01-19	CI
FoxWayne Enterprises Acquisition Corp. has filed an IPO in the amount of $50 million.	20-12-08	CI
FoxWayne Enterprises Acquisition Corp. announced that it expects to receive $2 million in funding from FoxWayne Enterprises Acquisition Sponsor LLC	20-12-07	CI
FoxWayne Enterprises Acquisition Corp. announced that it has received $0.025 million in funding from FoxWayne Enterprises Acquisition Sponsor LLC	20-10-14	CI

Chart FoxWayne Enterprises Acquisition Corp.

Duration

Period

Chart FoxWayne Enterprises Acquisition Corp.

More charts

Company Profile

FoxWayne Enterprises Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company focuses for a target business in the biotechnology and/or telemedicine sector of the healthcare industry in North America. The Company has operations and has no revenues.

Sector

Investment Holding Companies

More about the company

Sector Shell Companies

	1st Jan change	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+154.80%	7.88B
CHURCHILL CAPITAL CORP VII	+2.33%	984M
APPLE ISPORTS GROUP, INC.	+41.91%	883M
PERELLA WEINBERG PARTNERS	+18.23%	773M
ARES ACQUISITION CORPORATION II	+2.16%	667M
E7 GROUP	+5.03%	637M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ADMIRAL ACQUISITION LIMITED	+8.61%	528M
CAPITOL INVESTMENT CORP. VII	-.--%	500M

Shell Companies